Sernova (TSX:SVA) Cash And Cash Equivalents : C$5.02 Mil (As of Jul. 2024)

View and export this data going back to 1998. Start your Free Trial

What is Sernova Cash And Cash Equivalents?

Sernova's quarterly cash and cash equivalents declined from Jan. 2024 (C$6.51 Mil) to Apr. 2024 (C$3.44 Mil) but then increased from Apr. 2024 (C$3.44 Mil) to Jul. 2024 (C$5.02 Mil).

Sernova's annual cash and cash equivalents declined from Oct. 2021 (C$27.87 Mil) to Oct. 2022 (C$3.78 Mil) but then increased from Oct. 2022 (C$3.78 Mil) to Oct. 2023 (C$8.72 Mil).

Sernova Cash And Cash Equivalents Historical Data

The historical data trend for Sernova's Cash And Cash Equivalents can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sernova Cash And Cash Equivalents Chart

Sernova Annual Data

Trend

Oct14

Oct15

Oct16

Oct17

Oct18

Oct19

Oct20

Oct21

Oct22

Oct23

Cash And Cash Equivalents

Get a 7-Day Free Trial

1.80

3.95

27.87

3.78

8.72

Sernova Quarterly Data
	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24	Apr24	Jul24
Cash And Cash Equivalents	Get a 7-Day Free Trial															17.78	8.72	6.51	3.44	5.02

Sernova Cash And Cash Equivalents Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

Sernova (TSX:SVA) Cash And Cash Equivalents Explanation

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.

Be Aware

Depreciation estimates make the calculation of net income susceptible to management's accounting choices. These choices can be either overly aggressive or overly conservative.

Sernova Cash And Cash Equivalents Related Terms

Thank you for viewing the detailed overview of Sernova's Cash And Cash Equivalents provided by GuruFocus.com. Please click on the following links to see related term pages.

Sernova Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sernova Corp (TSX:SVA) » Definitions » Cash And Cash Equivalents

Comparable Companies

Traded in Other Exchanges

SEOVF:USA PSH:Germany PSH:Germany PSH:Germany

Address

700 Collip Circle, The Stiller Centre, Suite 114, London, ON, CAN, N6G 4X8

Website

https://www.sernova.com

Sernova Corp is a clinical-stage company developing products for the treatment of chronic debilitating diseases. The company is engaged in the research and development of its proprietary Cell Pouch and associated technologies including immune-protected therapeutic cells. The Cell Pouch is is a scalable, implantable medical device designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells, which then release proteins, hormones or other factors into the bloodstream for the long-term treatment of multiple chronic diseases such as type 1 diabetes, hypothyroid disease, and rare diseases such as hemophilia A.

Executives